Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155066214> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2155066214 endingPage "A350" @default.
- W2155066214 startingPage "A350" @default.
- W2155066214 abstract "Develop model simulating economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections (ABSSSIs) with suspected Methicillin-Resistant Staphylococcus aureus (MRSA) that considers antibiotic switches, course duration, route of administration and location of care (LOC). Discrete event simulation (DES) tracks patient pathways through various LOC (ED, inpatient, outpatient) during ABSSSI treatment for suspected MRSA. Model assumes 60% of patients hospitalized. Multiple pathways are allowed: patients responding can move to outpatient to finish treatment, switch treatment at discharge or receive 2nd line treatment if not responding. Patients accrue resource use, time in LOC and costs. Hospital days obtained from analysis of Premier Hospital Database. Three cohorts created; all assigned to receive vancomycin (VAN) 1st line therapy. Upon discharge, one cohort continued on VAN, one switched to oral linezolid (LIN), one to daptomycin (DAP) to complete treatment. Costs are from the Medicare perspective in 2012 USD. Hospital plus outpatient days range from 11.1 (VAN) to 14.5 (LIN); costs ranged from $6,983 (LIN) to $8,122 (VAN) with suspected MRSA. By comparison, reatment duration ranged from 9.97 (VAN) to 13.02 (LIN) and total costs ranged from $6,889 (LIN) to $9,354 (VAN) when MRSA is not always suspected. Despite longer LIN treatment, costs are lower because of avoided infusion costs. Outpatient costs account for 22% (LIN) to 33% (VAN) of total costs. Sensitivity analysis examined impact on cost when treatment duration varied per drug labeling. Total costs varied from $6,756 to $7,158 when duration of LIN ranges from 8 days to 12 days. Treatment choice and LOC have major impact on ABSSSI resource use and costs. Suspected MRSA increases treatment duration and cost. Economic implications for payers and providers should be evaluated using models that capture these elements in view of long-acting lipoglycopeptide IV antibiotics in development that avoid repeated infusions and may allow for less inpatient treatment." @default.
- W2155066214 created "2016-06-24" @default.
- W2155066214 creator A5017043744 @default.
- W2155066214 creator A5029607331 @default.
- W2155066214 creator A5042408270 @default.
- W2155066214 creator A5046196838 @default.
- W2155066214 creator A5068345138 @default.
- W2155066214 creator A5078840423 @default.
- W2155066214 date "2013-11-01" @default.
- W2155066214 modified "2023-09-27" @default.
- W2155066214 title "Economic Implications of Alternative Treatments and Care Locations for Acute Bacterial Skin and Skin Structure Infections with Suspected MRSA" @default.
- W2155066214 doi "https://doi.org/10.1016/j.jval.2013.08.166" @default.
- W2155066214 hasPublicationYear "2013" @default.
- W2155066214 type Work @default.
- W2155066214 sameAs 2155066214 @default.
- W2155066214 citedByCount "0" @default.
- W2155066214 crossrefType "journal-article" @default.
- W2155066214 hasAuthorship W2155066214A5017043744 @default.
- W2155066214 hasAuthorship W2155066214A5029607331 @default.
- W2155066214 hasAuthorship W2155066214A5042408270 @default.
- W2155066214 hasAuthorship W2155066214A5046196838 @default.
- W2155066214 hasAuthorship W2155066214A5068345138 @default.
- W2155066214 hasAuthorship W2155066214A5078840423 @default.
- W2155066214 hasBestOaLocation W21550662141 @default.
- W2155066214 hasConcept C121955636 @default.
- W2155066214 hasConcept C124306116 @default.
- W2155066214 hasConcept C126322002 @default.
- W2155066214 hasConcept C144133560 @default.
- W2155066214 hasConcept C160735492 @default.
- W2155066214 hasConcept C162324750 @default.
- W2155066214 hasConcept C175444787 @default.
- W2155066214 hasConcept C177713679 @default.
- W2155066214 hasConcept C182299520 @default.
- W2155066214 hasConcept C187212893 @default.
- W2155066214 hasConcept C194828623 @default.
- W2155066214 hasConcept C2778651397 @default.
- W2155066214 hasConcept C2778980435 @default.
- W2155066214 hasConcept C2779489039 @default.
- W2155066214 hasConcept C2781385661 @default.
- W2155066214 hasConcept C2781414143 @default.
- W2155066214 hasConcept C501593827 @default.
- W2155066214 hasConcept C50522688 @default.
- W2155066214 hasConcept C523546767 @default.
- W2155066214 hasConcept C54355233 @default.
- W2155066214 hasConcept C6964187 @default.
- W2155066214 hasConcept C71924100 @default.
- W2155066214 hasConcept C72563966 @default.
- W2155066214 hasConcept C86803240 @default.
- W2155066214 hasConcept C89423630 @default.
- W2155066214 hasConceptScore W2155066214C121955636 @default.
- W2155066214 hasConceptScore W2155066214C124306116 @default.
- W2155066214 hasConceptScore W2155066214C126322002 @default.
- W2155066214 hasConceptScore W2155066214C144133560 @default.
- W2155066214 hasConceptScore W2155066214C160735492 @default.
- W2155066214 hasConceptScore W2155066214C162324750 @default.
- W2155066214 hasConceptScore W2155066214C175444787 @default.
- W2155066214 hasConceptScore W2155066214C177713679 @default.
- W2155066214 hasConceptScore W2155066214C182299520 @default.
- W2155066214 hasConceptScore W2155066214C187212893 @default.
- W2155066214 hasConceptScore W2155066214C194828623 @default.
- W2155066214 hasConceptScore W2155066214C2778651397 @default.
- W2155066214 hasConceptScore W2155066214C2778980435 @default.
- W2155066214 hasConceptScore W2155066214C2779489039 @default.
- W2155066214 hasConceptScore W2155066214C2781385661 @default.
- W2155066214 hasConceptScore W2155066214C2781414143 @default.
- W2155066214 hasConceptScore W2155066214C501593827 @default.
- W2155066214 hasConceptScore W2155066214C50522688 @default.
- W2155066214 hasConceptScore W2155066214C523546767 @default.
- W2155066214 hasConceptScore W2155066214C54355233 @default.
- W2155066214 hasConceptScore W2155066214C6964187 @default.
- W2155066214 hasConceptScore W2155066214C71924100 @default.
- W2155066214 hasConceptScore W2155066214C72563966 @default.
- W2155066214 hasConceptScore W2155066214C86803240 @default.
- W2155066214 hasConceptScore W2155066214C89423630 @default.
- W2155066214 hasIssue "7" @default.
- W2155066214 hasLocation W21550662141 @default.
- W2155066214 hasOpenAccess W2155066214 @default.
- W2155066214 hasPrimaryLocation W21550662141 @default.
- W2155066214 hasRelatedWork W1890565529 @default.
- W2155066214 hasRelatedWork W2018382434 @default.
- W2155066214 hasRelatedWork W2089821540 @default.
- W2155066214 hasRelatedWork W2107437316 @default.
- W2155066214 hasRelatedWork W2111627732 @default.
- W2155066214 hasRelatedWork W2115172136 @default.
- W2155066214 hasRelatedWork W2125076516 @default.
- W2155066214 hasRelatedWork W2324699949 @default.
- W2155066214 hasRelatedWork W2518145627 @default.
- W2155066214 hasRelatedWork W2800223684 @default.
- W2155066214 hasVolume "16" @default.
- W2155066214 isParatext "false" @default.
- W2155066214 isRetracted "false" @default.
- W2155066214 magId "2155066214" @default.
- W2155066214 workType "article" @default.